Nuwellis Inc. (NUWE)
undefined
undefined%
At close: undefined
1.20
2.13%
After-hours Dec 13, 2024, 04:46 PM EST

Company Description

Nuwellis, Inc., a medical device company, focuses on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy.

The company's products are the Aquadex FlexFlow and Aquadex SmartFlow systems, which are indicated for the treatment of patients suffering from fluid overload who have failed diuretics.

Its Aquadex FlexFlow system includes a console, disposable blood set, and catheter.

The company sells its products to hospitals and clinics through its direct salesforce in the United States; and through independent specialty distributors primarily in Austria, Brazil, Czech Republic, Germany, Greece, Hong Kong, India, Israel, Italy, Romania, Singapore, Slovakia, Spain, Switzerland, Thailand, the United Arab Emirates, and the United Kingdom.

The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021.

Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.

Nuwellis Inc.
Nuwellis Inc. logo
Country United States
IPO Date Feb 16, 2012
Industry Medical - Devices
Sector Healthcare
Employees 59
CEO Nestor Jaramillo Jr.

Contact Details

Address:
12988 Valley View Road
Eden Prairie, Minnesota
United States
Website https://www.nuwellis.com

Stock Details

Ticker Symbol NUWE
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001506492
CUSIP Number 12542Q706
ISIN Number US67113Y4052
Employer ID 68-0533453
SIC Code 3845

Key Executives

Name Position
Nestor Jaramillo Jr. President, Chief Executive Officer & Director
Robert B. Scott Chief Financial Officer
Dr. John Lynn Jefferies FACC, M.B.A., M.D., M.P.H. Chief Medical Officer & Member of Medical Advisory Board
John Kowalczyk Senior Vice President of Sales & Marketing
Neil P. Ayotte Esq. Senior Vice President, General Counsel, Secretary & Chief Compliance Officer
Paul Wotta Corporate Controller
Sandra Eayrs Chief Human Resources Officer

Latest SEC Filings

Date Type Title
Nov 20, 2024 D Filing
Nov 15, 2024 S-1 Filing
Nov 12, 2024 10-Q Quarterly Report
Nov 12, 2024 8-K Current Report
Nov 07, 2024 8-K Current Report
Nov 01, 2024 8-K Current Report
Oct 23, 2024 8-K Current Report
Sep 06, 2024 424B3 Filing
Sep 04, 2024 D Filing
Aug 30, 2024 SC 13G Statement of acquisition of beneficial ownership b...